Rate Per 100,000 of Reported Cases by Age Group - Communicable Disease in New York State Exclusive of New York City - 2004

  <1 1-4 5-9 10-14 15-19 20-29 30-39 40-49 50-59 60+ Total
AIDS* 0.0 0.0 0.1 0.6 1.4 9.6 28.5 29.6 15.4 3.5 12.7
AMEBIASIS 0.0 1.7 1.7 1.3 1.1 1.4 1.1 1.1 1.4 0.8 1.2
BABESIOSIS 1.6 0.2 0.0 0.0 0.0 0.1 0.2 0.6 1.1 2.3 0.7
BOTULISM 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.01
BRUCELLOSIS 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.01
CAMPYLOBACTERIOSIS 30.3 19.0 9.3 7.2 11.4 12.5 13.7 14.4 11.9 10.0 12.4
CHLAMYDIA NA NA NA 53.8 1157.1 899.5 125.9 30.0 7.5 1.5 222.6
CHOLERA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.01
CRYPTOSPORIDIOSIS 3.1 5.7 3.0 2.0 2.7 2.4 1.4 1.1 0.6 0.5 1.7
CYCLOSPORA 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.1 0.2
DENGUE FEVER 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.01
E. COLI 0157 0.8 3.4 2.1 1.7 2.2 1.3 0.5 0.6 0.6 0.8 1.1
EHEC** 1.6 2.9 1.8 0.6 1.5 0.7 0.1 0.2 0.3 0.2 0.6
EHRLICHIOSIS 0.0 0.0 0.0 0.4 0.3 0.4 1.0 1.1 1.3 1.9 0.9
ENCEPHALITIS (NON-WEST NILE) 3.9 0.0 0.6 0.3 0.0 0.2 0.5 0.4 0.5 1.1 0.5
GIARDIASIS 28.8 53.8 28.5 8.9 7.7 9.0 13.2 13.0 10.4 8.1 13.8
GONORRHEA NA NA NA 15.0 266.3 259.1 75.8 30.6 9.4 1.8 69.5
HAEMOPHILUS INFLUENZAE 6.2 1.1 0.6 0.1 0.1 0.2 0.3 0.8 0.7 4.4 1.3
HEMOLYTIC UREMIC SYNDROME 0.0 1.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1
HEPATITIS A 0.0 1.7 1.6 1.3 2.3 1.1 0.9 0.7 1.0 0.7 1.1
HEPATITIS B - ACUTE 0.0 0.0 0.0 0.0 0.1 1.2 1.6 1.3 1.4 0.3 0.8
HEPATITIS C - ACUTE 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.4 0.1 0.05 0.2
LEGIONELLOSIS 0.8 0.0 0.0 0.0 0.3 0.2 0.9 0.7 1.6 3.4 1.1
LISTERIOSIS 3.1 0.0 0.0 0.0 0.0 0.2 0.6 0.2 0.6 1.3 0.5
LYME DISEASE 11.7 48.4 69.1 50.6 36.3 21.8 32.1 42.3 52.2 46.7 42.7
MALARIA 0.8 0.2 0.1 0.0 0.6 1.2 0.7 0.5 0.6 0.3 0.5
MEASLES 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.01
MENINGITIS ASEPTIC 51.3 4.6 10.1 7.7 5.6 5.3 7.7 4.3 3.0 1.8 5.6
MENINGOCOCCAL 1.6 2.1 0.4 0.1 0.4 0.2 0.3 0.2 0.3 0.4 0.4
MUMPS 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1
PERTUSSIS 149.3 38.5 30.4 83.9 39.9 5.6 6.4 6.7 4.0 1.5 17.7
RMSF 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.01
SALMONELLOSIS 52.9 35.4 16.8 10.8 11.8 11.5 10.0 8.1 7.8 8.4 11.6
SHIGELLOSIS 3.9 28.9 14.6 3.7 1.9 2.9 1.9 1.0 1.3 1.1 3.9
STREP GROUP A INVASIVE 4.7 1.9 1.3 0.4 0.3 0.7 1.4 2.3 2.2 5.9 2.3
STREP GROUP B INVASIVE 42.8 0.2 0.1 0.1 0.4 1.2 1.7 2.9 6.8 18.5 5.6
STREP PNEUMONIA INVASIVE*** 28.8 13.4 2.8 1.7 1.5 2.1 3.1 7.7 12.3 29.8 10.4
SYPHILIS EARLY NA NA NA 0.3 0.8 2.6 4.3 2.2 1.4 0.1 1.6
SYPHILIS LATE NA NA NA 0.0 1.5 4.8 8.6 8.2 7.2 5.8 5.2
TETANUS 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.01
TOXIC SHOCK SYNDROME 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.05 0.04
TUBERCULOSIS 2.3 2.5 0.4 0.9 1.3 4.8 3.2 3.1 2.6 3.9 2.9
TYPHOID FEVER 0.8 0.4 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.05 0.1
VRSA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.05 0.01
WEST NILE FEVER 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.05 0.01
WEST NILE VIRUS 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.05
YERSINIOSIS 1.6 0.4 0.0 0.4 0.3 0.1 0.1 0.1 0.3 0.3 0.2

*Based on Report year (excludes inmates). Provisional, data as of July 5, 2005.
**E.coli non-O157 and not sero-grouped shigatoxin producing infection
***Resistant, Sensitive, Intermediate, & Unknown